Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending August 18, 2003. The report serves to disclose changes in directors' interests in the company's Ordinary Shares and American Depositary Receipts (ADRs) as required by the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a disclosure of equity transactions and does not contain financial performance data.
Material Changes
The filing details specific changes in shareholdings related to employee benefit plans and director interests:
- August 14, 2003: The GlaxoSmithKline Employee Trust (GSK Trust) transferred 4,510 Ordinary Shares on behalf of participants in the SmithKline Beecham Employee Share Option Plan 1991.
- August 15, 2003: The GSK Trust transferred an additional 46,790 Ordinary Shares for the same plan.
- August 18, 2003: The GlaxoSmithKline US Retirement Savings Plan saw an increase in Ordinary Share ADRs from 18,932,799 to 18,990,876 due to fund movements on August 15, 2003. The average price was $39.85.
Management Commentary and Risks
The filing notes that Directors Dr. J-P Garnier and Mr. J D Coombe are interested in shares held in the GSK Trust, and Dr. J-P Garnier is potentially interested in shares held in the US Retirement Savings Plan, in the same capacity as other employees. No specific guidance, outlook, or risk factors regarding business operations are provided in this text.
Investor Verification Checklist
- Verify the total number of shares transferred by the GSK Trust during the reporting period (51,300 shares total).
- Confirm the updated ADR holdings of the US Retirement Savings Plan (18,990,876 shares).
- Review the specific terms of the SmithKline Beecham Employee Share Option Plan 1991 to understand the context of the share transfers.
- Note that this filing contains no financial performance data; refer to Form 20-F for quarterly or annual financial results.